Prescribing SSRIs during late childhood to those with genetic risk factors for psychosis can reduce the deterioration of intellectual abilities, a new study reveals. SSRIs appear to have a neuroprotective effect for certain brain areas associated with the onset of psychosis if provided early.
Researchers report that by increasing the excitability of a subpopulation of hippocampal inhibitory neurons, certain behavioral symptoms associated with schizophrenia can be suppressed.
Researchers have identified brain differences in people with a genetic risk factor for autism and schizophrenia.
A new study find the deletion of a specific gene associated with schizophrenia leads to abnormal differentiation of neurons in the brain.